Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Progenics Pharmaceuticals (PGNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Help

Go To:

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

Previous Next

	09-2012	06-2012	03-2012	12-2011	09-2011
Cash Flows From Operating Activities
Net Income	-35,107	-23,806	-13,086	10,381	21,127
Depreciation Amortization	1,063	772	472	2,066	1,581
Accounts receivable	387	-580	-887	767	-229
Other Working Capital	-313	-3,634	-3,696	-422	-615
Other Operating Activity	5,056	5,159	3,403	5,595	4,924
Operating Cash Flow	$-28,914	$-22,089	$-13,794	$18,387	$26,788

Cash Flows From Investing Activities
PPE Investments	-391	-468	-394	-226	-142
Sale Of Investment	100	100	100	300	200
Investing Cash Flow	$-291	$-368	$-294	$74	$58

Cash Flows From Financing Activities
Common Stock Issued	196	172	82	3,726	3,234
Financing Cash Flow	$196	$172	$82	$3,726	$3,234

Beginning Cash Position	70,105	70,105	70,105	47,918	47,918
End Cash Position	41,096	47,820	56,099	70,105	77,998
Net Cash Flow	$-29,009	$-22,285	$-14,006	$22,187	$30,080

Free Cash Flow
Operating Cash Flow	-28,914	-22,089	-13,794	18,387	26,788
Capital Expenditure	-759	-731	-518	-226	-142
Free Cash Flow	-29,673	-22,820	-14,312	18,161	26,646